Skip to main content

Social Distancing, Health Care Disruptions, Telemedicine Use, and Treatment Interruption During the COVID-19 Pandemic in Patients With or Without Autoimmune Rheumatic Disease

By November 2, 2021December 9th, 2021COVID-19

Impacts from the COVID-19 pandemic were studied in patients with and without autoimmune rheumatic diseases. The authors aimed to compare concerns, social distancing, healthcare disruptions, and telemedicine use in these patients. Concerns about COVID-19 and social distancing behaviors were similar in both groups although patients receiving a biologic or Janus kinase (JAK) inhibitor reported greater concerns and were more likely to avoid leaving the house and engage in social activities. Patients with autoimmune rheumatic diseases were less likely to avoid office visits with similar telemedicine use. Missed office visits were strongly associated with interruptions in immunomodulatory medication.

Click here to read more